Los 10 mejores resultados encontrados para "limits proponent for médicas contra of hiv mitos" en Recursos. Para acceder a todos los resultados y disfrutar de otras funciones, regístrate de forma gratuita.
... Screening and Diagnostic Testing forHIV Infection in Adults — Wolters Kluwer UpToDate
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
VIH: PrEP y PEP — MedlinePlus (NIH)
...
... Screening and Diagnostic Testing forHIV Infection in Adults — Wolters Kluwer UpToDate
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
VIH: PrEP y PEP — MedlinePlus (NIH)
...
... Aidsmap
VIH: PrEP y PEP — MedlinePlus
Emtricitabine and Tenofovir — MedlinePlus
Profilaxis preexposición (PrEP) — HIVInfo.NIH.gov
Profilaxis posterior a la exposición — HIV.gov
How HIV Spreads — Centers for Disease Control and Prevention
Voluntary Medical Male Circumcisions forHIV Prevention — Morbidity and Mortality Weekly Report ...
... Aidsmap
VIH: PrEP y PEP — MedlinePlus
Emtricitabine and Tenofovir — MedlinePlus
Profilaxis preexposición (PrEP) — HIVInfo.NIH.gov
Profilaxis posterior a la exposición — HIV.gov
How HIV Spreads — Centers for Disease Control and Prevention
Voluntary Medical Male Circumcisions forHIV Prevention — Morbidity and Mortality Weekly Report ...
... — AIDS Healthcare Foundation
Ways To Stop HIV Stigma and Discrimination — Centers for Disease Control and Prevention
HIV Stigma and Discrimination— Centers for Disease Control and Prevention
Women’s Perceptions ofHIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa — AIDS and Behavior ...
... — AIDS Healthcare Foundation
Ways To Stop HIV Stigma and Discrimination — Centers for Disease Control and Prevention
HIV Stigma and Discrimination— Centers for Disease Control and Prevention
Women’s Perceptions ofHIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa — AIDS and Behavior ...
... — HIV.gov
Management of Health Care Personnel Exposed to HIV — Wolters Kluwer UpToDate
Preguntas frecuentes con relación al VIH y el sida — ONUSIDA
Harm Reduction To Lessen HIV Risks — National Institute of Allergy and Infectious Diseases
Profilaxis posexposición (PEP) — HIVinfo
Prueba de carga viral — MedlinePlus
...
... — HIV.gov
Management of Health Care Personnel Exposed to HIV — Wolters Kluwer UpToDate
Preguntas frecuentes con relación al VIH y el sida — ONUSIDA
Harm Reduction To Lessen HIV Risks — National Institute of Allergy and Infectious Diseases
Profilaxis posexposición (PEP) — HIVinfo
Prueba de carga viral — MedlinePlus
...
... — Mayo Clinic
HIV Infection and Cancer Risk — National Cancer Institute
Herpes: HSV-1 and HSV-2 — Johns Hopkins Medicine
QuickFacts: United States — United States Census Bureau
U.S. Statistics — HIV.gov ...
... — Mayo Clinic
HIV Infection and Cancer Risk — National Cancer Institute
Herpes: HSV-1 and HSV-2 — Johns Hopkins Medicine
QuickFacts: United States — United States Census Bureau
U.S. Statistics — HIV.gov ...
... ofHIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment ofHIV-2 Infection — Wolters Kluwer UpToDate ...
... ofHIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment ofHIV-2 Infection — Wolters Kluwer UpToDate ...
únete
